Fraud and Abuse: Issues Related to the 340B Program

In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks to Todd Nova, Shareholder, Hall Render, about issues related to the 340B drug discount program. They discuss discrepancies in how federal courts are interpreting the program’s requirements around contract pharmacies, issues related to drug diversion and duplicate discounts, legislative and regulatory developments, and predictions for 2022 and beyond. From AHLA's Fraud and Abuse Practice Group. Sponsored by BRG.